A detailed history of Salomon & Ludwin, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Salomon & Ludwin, LLC holds 3,379 shares of ABT stock, worth $397,911. This represents 0.04% of its overall portfolio holdings.

Number of Shares
3,379
Previous 3,332 1.41%
Holding current value
$397,911
Previous $346,000 11.27%
% of portfolio
0.04%
Previous 0.04%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

BUY
$100.07 - $118.13 $4,703 - $5,552
47 Added 1.41%
3,379 $385,000
Q2 2024

Jul 25, 2024

SELL
$100.73 - $112.44 $433,038 - $483,379
-4,299 Reduced 56.34%
3,332 $346,000
Q1 2024

May 02, 2024

BUY
$109.52 - $120.96 $14,894 - $16,450
136 Added 1.81%
7,631 $867,000
Q2 2023

Jul 21, 2023

BUY
$100.78 - $112.29 $40,312 - $44,916
400 Added 5.64%
7,495 $817,000
Q4 2022

Feb 08, 2023

SELL
$95.06 - $111.52 $8,840 - $10,371
-93 Reduced 1.29%
7,095 $779,000
Q3 2022

Nov 03, 2022

BUY
$96.76 - $112.03 $443,064 - $512,985
4,579 Added 175.51%
7,188 $696,000
Q2 2022

Aug 03, 2022

SELL
$102.07 - $123.37 $3,368 - $4,071
-33 Reduced 1.25%
2,609 $283,000
Q1 2022

May 06, 2022

BUY
$114.02 - $139.04 $3,762 - $4,588
33 Added 1.26%
2,642 $313,000
Q4 2021

Feb 04, 2022

BUY
$115.53 - $141.46 $301,417 - $369,069
2,609 New
2,609 $367,000
Q2 2020

Jul 17, 2020

SELL
$76.57 - $98.0 $20,520 - $26,264
-268 Closed
0 $0
Q1 2020

Apr 03, 2020

SELL
$62.82 - $91.86 $43,974 - $64,302
-700 Reduced 72.31%
268 $21,000
Q4 2019

Feb 07, 2020

BUY
$78.51 - $87.4 $54,957 - $61,180
700 Added 261.19%
968 $84,000
Q2 2019

Aug 20, 2019

SELL
$72.88 - $85.0 $13,118 - $15,300
-180 Reduced 40.18%
268 $23,000
Q4 2018

Feb 13, 2019

BUY
$65.56 - $74.27 $29,370 - $33,272
448 New
448 $32,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $206B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Salomon & Ludwin, LLC Portfolio

Follow Salomon & Ludwin, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Salomon & Ludwin, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Salomon & Ludwin, LLC with notifications on news.